These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11390725)

  • 1. Effect of type of dialysis membrane on bone in haemodialysis patients.
    Ferreira A; Ghazali A; Galvão J; Souberbielle JC; Jehle PM; Mohan S; Descamps-Latscha B; Oprisiu R; Fournier A; Drüeke TB
    Nephrol Dial Transplant; 2001 Jun; 16(6):1230-8. PubMed ID: 11390725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
    Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.
    Pietrzyk B; Wyskida K; Ficek J; Kolonko A; Ficek R; Więcek A; Olszanecka-Glinianowicz M; Chudek J
    Int Urol Nephrol; 2019 Mar; 51(3):519-526. PubMed ID: 30584645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3.
    Bohé J; Joly MO; Arkouche W; Laville M; Fouque D
    Nephrol Dial Transplant; 2001 Mar; 16(3):590-4. PubMed ID: 11239037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
    Fiedler R; Deuber HJ; Langer T; Osten B; Mohan S; Jehle PM
    Nephron Clin Pract; 2004; 96(1):c3-9. PubMed ID: 14752247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Pasquali M; Perruzza I; Manni M; Sardella D
    Miner Electrolyte Metab; 1991; 17(3):153-9. PubMed ID: 1779936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
    Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
    J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of haemodialysis on markers of bone turnover in children.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
    Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
    Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Bone Histomorphometry after Kidney Transplantation.
    Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.
    Sugimoto T; Kaji H; Nakaoka D; Yamauchi M; Yano S; Sugishita T; Baylink DJ; Mohan S; Chihara K
    Eur J Endocrinol; 2002 Sep; 147(3):339-48. PubMed ID: 12213671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.